07:00 , Sep 5, 2013 |  BC Innovations  |  Distillery Techniques

Technology: Disease models

Approach Summary Licensing status Publication and contact information Disease models Transgenic, humanized mouse model of HCV infection Partially immunocompromised, humanized mice could be used as a model of HCV infection to help evaluate antiviral drug...
07:00 , Jul 7, 2008 |  BC Week In Review  |  Company News

Apath, Diagnostic Hybrids, Case Western Reserve University, University Hospitals of Cleveland Center for AIDS Research, Third Frontier Commission diagnostic, in

The commission awarded a three-year, $5 million grant to Apath, Diagnostic Hybrids and the universities to develop tests, treatments and vaccines for drug resistant HIV, HCV and influenza. The partners will use Diagnostic Hybrids’ yeast-based...
08:00 , Nov 22, 2004 |  BC Week In Review  |  Company News

Apath, Nucleonics deal

Apath granted Nucleonics a non-exclusive license to technology related to the 3' non-translated region of the hepatitis C viral (HCV) genome. Nucleonics will use it as a target for developing an expressed RNAi therapeutic for...